Income StatementBalance SheetCash FlowSegments
Pfizer logo

Pfizer Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Pfizer holds $207.62B in total assets. Shareholders' equity is $90.1B against $64.4B in total debt. Cash and equivalents total $1.8B. The current ratio is 1.25 and debt-to-equity is 0.715. Based on the Q1 2026 filing.

Total Assets$207.62BTotal Stockholders Equity$90.1BLong Term Debt$60.6BCash And Equivalents$1.8BTotal Current Assets$42.8BTotal Current Liabilities$34.3B
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$147.62B
P/E Ratio12.19
ROE13.42%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$5.6B$5.2B$5.2B$5.0B$5.2B$4.5B
Accrued Manufacturing Costs$3.8B$2.6B$2.4B$3.0B$3.6B$2.7B
Compensation and benefits$3.8B$2.6B$2.4B$3.0B$3.6B$2.7B
Other accrued liabilities$19.7B$20.0B$18.6B$19.5B$19.4B$20.1B
Other short-term debt$755.0M$567.0M$50.0M$56.0M$157.0M$29.0M
Current portion of long-term debt$3.7B$3.7B$4.2B$4.2B$3.0B$3.9B
Derivative Liabilities - Fair Value$1.4B$1.3B$1.9B$1.6B$1.5B$1.4B
Dividends payable$2.4B$0.0$2.4B$0.0$2.4B$0.0
Income taxes payable$2.9B$3.1B$3.7B$3.8B$3.1B$3.1B
Supplier Finance Program Obligations$688.0M$546.0M$501.0M$566.0M$574.0M$518.0M
Total current liabilities$43.0B$36.5B$37.7B$36.6B$37.0B$34.3B
Total Debt, Gross$7.0B$4.5B$4.3B$4.3B$3.2B$3.9B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$11.5B$11.8B$12.1B$14.3B$11.9B$12.6B
Allowance for Doubtful Accounts$438.0M$427.0M$439.0M$434.0M$427.0M$425.0M
Cash and cash equivalents$1.1B$1.5B$1.7B$1.4B$1.2B$1.8B
Available For Sale Securities Debt Securities Current$10.9B$14.0B$9.5B$10.1B$9.2B$8.2B
Derivatives————$416.0M$504.0M
Finished goods$3.8B$4.2B$4.1B$4.5B$4.1B$4.0B
Materials and supplies$976.0M$1.1B$1.0B$945.0M$907.0M$923.0M
Other current assets$4.3B$2.9B$2.7B$2.4B$2.8B$2.9B
Securities Received As Collateral—$564.0M$43.0M$56.0M—$29.0M
Total Debt Securities (Trading and AFS)————$9.9B$9.6B
Derivative Assets, Current————$416.0M$504.0M
Derivative Assets - Fair Value—$487.0M$42.0M$60.0M$116.0M$41.0M
Derivative assets$1.5B$842.0M$367.0M$418.0M$532.0M$659.0M
Work in process$6.1B$5.6B$6.5B$6.0B$5.6B$5.7B
Inventories$2.7B$2.8B$2.4B$2.1B$2.4B$2.5B
Short-term investments$19.4B$15.9B$11.6B$13.6B$12.5B$11.4B
Total current assets$50.4B$45.9B$43.7B$46.9B$42.9B$42.8B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$93.6B$93.9B$94.1B$94.2B$94.5B$94.8B
Accumulated other comprehensive income (loss)-$7.8B-$8.6B-$8.4B-$8.1B-$8.1B-$7.2B
Debt Securities (Trading and AFS) - Accumulated Gross Unrealized Gain$8.0M$39.0M$87.0M$2.0M$3.0M$29.0M
Debt Securities (Trading and AFS) - Accumulated Gross Unrealized Loss$129.0M$36.0M$1.0M$24.0M$35.0M$2.0M
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$480.0M$481.0M$481.0M$481.0M$481.0M$482.0M
Retained earnings$116.7B$119.6B$117.6B$121.2B$114.6B$117.2B
Total liabilities and stockholders' equity$213.4B$208.0B$206.1B$208.7B$208.2B$207.6B
Total stockholders' equity$88.2B$90.3B$88.7B$92.8B$86.5B$90.1B
Treasury stock$114.8B$115.0B$115.0B$115.0B$115.0B$115.2B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Available-for-Sale and Held-to-Maturity Debt Securities$11.8B$14.9B$10.4B$11.5B$9.9B$9.6B
Deferred tax assets$2.1B$2.3B$2.5B$2.5B$2.4B-$12.0M
Deferred Tax Assets and Other Non-Current Assets$9.8B$9.8B$9.5B$9.3B$9.6B$9.8B
Derivative Assets, Non-Current————$116.0M$155.0M
Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss—$400.0M$435.0M$467.0M—$444.0M
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments—$223.0M$239.0M$239.0M—$225.0M
Equity Securities (Non-Current)$1.2B$1.0B$1.1B$1.2B$642.0M$653.0M
Goodwill$68.5B$68.4B$69.0B$69.1B$71.3B$71.4B
Indefinite-Lived Intangible Assets$19.6B$19.4B$18.7B$17.8B$22.2B$21.6B
Indefinite-Lived Intangible Assets, Gross$19.6B$19.4B$18.7B$17.8B$22.2B$21.6B
Indefinite-Lived Research and Development Assets$19.6B$19.4B$18.7B$17.8B$22.2B$21.6B
Indefinite-Lived Trademarks$19.6B$19.4B$18.7B$17.8B$22.2B$21.6B
Equity securities$7.8B$1.3B$1.7B$2.4B$2.6B$1.9B
Long-term marketable securities$0.0—$1.0M$1.0M$1.0M$0.0
Noncurrent deferred tax assets and other noncurrent tax assets$8.7B$9.5B$10.3B$11.0B$9.7B$10.0B
Intangible assets — net$35.8B$34.6B$34.0B$33.5B$31.5B$30.9B
Held To Maturity Securities Noncurrent$45.0M$47.0M$48.0M$48.0M$48.0M$47.0M
Other intangible assets—net$55.4B$54.0B$52.7B$51.3B$53.7B$52.6B
Other non-current assets$9.8B$9.8B$9.5B$9.3B$9.6B$9.8B
Strategic investments$2.2B$1.8B$1.9B$2.1B$1.6B$1.6B
Current tax assets$3.3B$2.9B$4.0B$3.9B$4.0B$3.6B
Other Investments$2.2B$1.8B$1.9B$2.1B$1.6B$1.6B
Accumulated depreciation$16.5B$16.8B$17.3B$17.5B$17.4B$17.8B
Property and equipment, net$18.4B$18.3B$18.8B$18.9B$19.3B$19.4B
Software and Technology Licenses, Net$9.8B$9.8B$9.5B$9.3B$9.6B$9.8B
Total assets$213.4B$208.0B$206.1B$208.7B$208.2B$207.6B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross Assets/Liabilities$1.4B$1.3B$1.9B$1.6B$1.5B$1.4B
Allowance for doubtful accounts$438.0M$427.0M$439.0M$434.0M$427.0M$425.0M
Business Combination, Contingent Consideration, Liability, Noncurrent————$1.7B$1.9B
Business Combination, Contingent Consideration, Liability, Current————$95.0M$95.0M
Collateral already posted, aggregate fair value—$640.0M$1.1B$1.2B—$1.2B
Short-term debt and current portion of long-term debt$6.9B$4.5B$4.3B$4.3B$3.2B$3.9B
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net$12.0M$1.0M$4.0M$3.0M$3.0M$3.0M
Debt Securities, Amortized Cost Basis$11.9B$14.9B$10.3B$11.6B$9.9B$9.5B
Debt Securities Maturities, After Year Five, Fair Value—$21.0M$34.0M$33.0M—$38.0M
Debt Securities Maturities, Next Twelve Months, Fair Value—$14.9B$10.3B$11.5B—$9.5B
Debt Securities Maturities, Year Two Through Five, Fair Value—$26.0M$14.0M$16.0M—$10.0M
Deferred income taxes$2.1B$2.3B$2.5B$2.5B$2.4B$2.4B
Derivatives————$116.0M$155.0M
Derivative Liability$1.4B$1.3B$1.9B$1.6B$1.5B$1.4B
Derivative, Net Liability Position, Aggregate Fair Value—$646.0M$1.1B$1.1B—$1.1B
Equity method investments (Note 11)$217.0M$224.0M$224.0M$223.0M$235.0M$237.0M
Long-term equity securities held in trust————$146.0M$147.0M
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value$517.0M$477.0M——$1.8B$2.0B
Finite-Lived Intangible Assets, Accumulated Amortization$67.5B$68.8B$70.5B$71.3B$72.5B$73.9B
Gross Carrying Amount$103.4B$103.4B$104.6B$104.8B$104.0B$104.8B
Fair value hedge adjustments on discontinued hedges————$821.0M$803.0M
Carrying values of hedged liabilities————$7.1B$8.4B
Cumulative amount of fair value hedging adjustment————-$163.0M-$248.0M
Trademarks$19.6B$19.4B$18.7B$17.8B$22.2B$21.6B
Indefinite- lived intangible impairment$123.0B$122.8B$123.2B$122.7B$126.2B$126.4B
Liabilities, Current, Fair Value Disclosure————$523.0M$379.0M
Liabilities, Noncurrent, Fair Value Disclosure————$2.7B$3.0B
Insurance contracts————$999.0M$950.0M
Current portion of long-term debt, principal amount$3.8B$3.8B$4.3B$4.3B$3.0B$3.9B
Noncontrolling interests in subsidiaries$294.0M$299.0M$317.0M$295.0M$299.0M$303.0M
Other Assets, Noncurrent, Fair Value Disclosure————$1.1B$1.1B
Private equity securities at cost$719.0M$712.0M$729.0M$690.0M$696.0M$688.0M
Total accrued rebates and other sales-related accruals$10.8B$10.9B$11.7B$12.9B$11.7B$11.6B
Restructuring Reserve$2.1B$2.4B$2.0B$1.8B$1.9B$1.6B
Threshold for disclosure of proceedings under environmental laws—$1.0M$1.0M$1.0M—$1.0M
Long-term income taxes—$15.0B$15.0B$15.0B—$15.0B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Long-term debt$57.4B$57.6B$57.5B$57.4B$61.6B$60.6B
Liability For Uncertain Tax Positions Noncurrent$6.1B$5.7B$3.3B$3.4B$3.6B$3.7B
Retirement and nonpension postretirement benefit obligations$2.1B$2.0B$2.1B$2.2B$2.0B$2.0B
Other non-current liabilities$14.2B$13.3B$13.9B$13.6B$14.7B$14.2B
Total liabilities$124.9B$117.4B$117.1B$115.6B$3.2B$3.4B